Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression

Fibroblast growth factor receptor 2 (FGFR2) has been identified as a predictive biomarker for unfavorable prognosis of gastric adenocarcinoma. As a well-defined antagonist in FGFR2-induced RAS/ERK activation, ectopic expression of sprouty (SPRY) family was reported in several kinds of cancers except...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunfei, Yang, Xiaoqing, Li, Zhen, Li, Shuo, Guo, Sen, Ismail, Sayed, Liu, Hongda, Huang, Zhihong, Zhang, Zongli, Chen, Yuxin, Sun, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354878/
https://www.ncbi.nlm.nih.gov/pubmed/28002800
http://dx.doi.org/10.18632/oncotarget.13982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354878/
https://www.ncbi.nlm.nih.gov/pubmed/28002800
http://dx.doi.org/10.18632/oncotarget.13982

Ejemplares similares